Cited by 87Medication Adherence and ComplianceBlood Pressure and Hypertension StudiesPharmacy and Medical Practices

Assessing Adherence to Antihypertensive Therapy in Primary Health Care in Namibia: Findings and Implications

Open access
Nashilongo, M. M., Singu, B., Kalemeera, F., Mubita, M., Naikaku, E., Baker, A., Ferrario, A., Godman, B. +2 more·2017·Cardiovascular Drugs and Therapy

Abstract

INTRODUCTION: Namibia has the highest burden and incidence of hypertension in sub-Sahara Africa. Though non-adherence to antihypertensive therapy is an important cardiovascular risk factor, little is known about potential ways to improve adherence in Namibia following universal access. The objective of this study is to validate the Hill-Bone compliance scale and determine the level and predictors of adherence to antihypertensive treatment in primary health care settings in sub-urban townships of Windhoek, Namibia. METHODS: Reliability was determined by Cronbach's alpha. Principal component analysis (PCA) was used to assess construct validity. RESULTS: The PCA was consistent with the three constructs for 12 items, explaining 24.1, 16.7 and 10.8% of the variance. Cronbach's alpha was 0.695. None of the 120 patients had perfect adherence to antihypertensive therapy, and less than half had acceptable levels of adherence (≥ 80%). The mean adherence level was 76.7 ± 8.1%. Three quarters of patients ever missed their scheduled clinic appointment. Having a family support system (OR = 5.4, 95% CI 1.687-27.6, p = 0.045) and attendance of follow-up visits (OR = 3.1, 95% CI 1.1-8.7, p = 0.03) were significant predictors of adherence. Having HIV/AIDs did not lower adherence. CONCLUSIONS: The modified Namibian version of the Hill-Bone scale is reliable and valid for assessing adherence to antihypertensives in Namibia. There is sub-optimal adherence to antihypertensive therapy among primary health cares in Namibia. This needs standardized systems to strengthen adherence monitoring as well as investigation of other factors including transport to take full advantage of universal access.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10557-017-6756-8

Cites

0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Patient adherence to hypertension treatment in other sub-Saharan African countries has been assessed through surveys, with adherence levels ranging from 17% in Kampala, Uganda to 61.8% in Ethiopia.

    “These surveys have found levels of adherence ranging from 17% in a survey of 112 hypertensive patients in two city hospitals in Kampala, Uganda, to 61.8% of patients compliant with antihypertensive medications at Jimma University Specialised Hospital in Ethiopia.9,10”

    From The outpatient management of hypertension at two Sierra Leonean health centres: A mixed-method investigation of follow-up compliance and patient-reported barriers to care (2020) · cites this paper as [11]

    The Discussion compares adherence findings in Namibia with studies in other African countries, so the source supports the general point that adherence has been assessed elsewhere. It does not report the claimed 17% result from Kampala or 61.8% result from Jimma; searches for those figures and locations found no matching passage. Page numbers were not available in our copy. (LLM, conf=0.78)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 37

  1. [2]Ataklte F Erqou S Kaptoge S Taye B Echouffo-Tcheugui JB Kengne AP Burden of undiagnosed hypertension in Sub-Saharan Africa: a systematic review and meta-analysis Hypertension 2015 65 2 291 298 10.1161/HYPERTENSIONAHA.114.04394 25385758 · DOI · Paper page
  2. [3]Lawes CM Vander Hoorn S Rodgers A Global burden of blood-pressure-related disease, 2001 Lancet 2008 371 9623 1513 1518 10.1016/S0140-6736(08)60655-8 18456100 · DOI
  3. [4]Irazola VE Gutierrez L Bloomfield G Carrillo-Larco RM Dorairaj P Gaziano T Hypertension prevalence, awareness, treatment, and control in selected low and middle income countries (LMIC) communities: results from the NHLBI/UHG Network of Centers of Excellence for Chronic Diseases Glob Heart 2016 11 1 47 59 10.1016/j.gheart.2015.12.008 27102022 PMC4843831 · DOI
  4. [6]Nielsen JO Shrestha AD Neupane D Kallestrup P Non-adherence to anti-hypertensive medication in low- and middle-income countries: a systematic review and meta-analysis of 92443 subjects J Hum Hypertens 2017 31 1 14 21 10.1038/jhh.2016.31 27306087 · DOI
  5. [7]Hendriks ME Wit FWNM Roos MTL Brewster LM Akande TM de Beer IH Hypertension in Sub-Saharan Africa: cross-sectional surveys in four rural and urban communities PLoS One 2012 7 3 e32638 10.1371/journal.pone.0032638 22427857 PMC3299675 · DOI
  6. [8]Chobanian AV Bakris GL Black HR Cushman WC Green LA Izzo JL Jr Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure Hypertension 2003 42 6 1206 1252 10.1161/01.HYP.0000107251.49515.c2 14656957 · DOI · Paper page
  7. [13]Krousel-Wood M Thomas S Muntner P Morisky D Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients Curr Opin Cardiol 2004 19 4 357 362 10.1097/01.hco.0000126978.03828.9e 15218396 · DOI
  8. [14]Calhoun DA Jones D Textor S Goff DC Murphy TP Toto RD Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research Hypertension 2008 51 6 1403 1419 10.1161/HYPERTENSIONAHA.108.189141 18391085 · DOI
  9. [15]Mant J McManus RJ Does it matter whether patients take their antihypertensive medication as prescribed? The complex relationship between adherence and blood pressure control J Hum Hypertens 2006 20 8 551 553 10.1038/sj.jhh.1002046 16710290 · DOI
  10. [18]Ministry of Health and Social Services. National medicines policy 2nd edition. Republic of Namibia Ministry of Health and Social Services, Windhoek, Namibia. 2011.
  11. [20]Cameron A Ewen M Ross-Degnan D Ball D Laing R Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis Lancet 2009 373 9659 240 249 10.1016/S0140-6736(08)61762-6 19042012 · DOI · Paper page
  12. [21]Bell R Ithindi T Low A Improving equity in the provision of primary health care: lessons from decentralized planning and management in Namibia Bull World Health Organ 2002 80 8 675 681 12219160 PMC2567583
  13. [22]Mweene D Banda J Andrews B M-Mweene M Lakhi S Factors associated with poor medication adherence in hypertensive patients in Lusaka, Zambia Med J Zambia 2010 37 3 252 261 PMC3866919 24363467
  14. [24]Kim MT Hill MN Bone LR Levine DM Development and testing of the hill-bone compliance to high blood pressure therapy scale Prog Cardiovasc Nurs 2000 15 3 90 96 10.1111/j.1751-7117.2000.tb00211.x 10951950 · DOI · Paper page
  15. [26]Dehghan M Nayeri ND Iranmanesh S Validating the Persian version of the Hill-Bone’s scale of “compliance to high blood pressure therapy” Br J Med Med Res 2015 5 2 235 246 10.9734/BJMMR/2015/13061 · DOI
  16. [27]Lambert EV Steyn K Stender S Everage N Fourie JM Hill M Cross-cultural validation of the hill-bone compliance to high blood pressure therapy scale in a South African, primary healthcare setting Ethn Dis 2006 16 286 291 16599385
  17. [28]Culig J Leppee M From Morisky to Hill-bone; self-reports scales for measuring adherence to medication Coll Antropol 2014 38 1 55 62 24851597
  18. [29]Berra E Azizi M Capron A Hoieggen A Rabbia F Kjeldsen SE Evaluation of adherence should become an integral part of assessment of patients with apparently treatment-resistant hypertension Hypertension 2016 68 2 297 306 10.1161/HYPERTENSIONAHA.116.07464 27296995 · DOI · Paper page
  19. [30]Inkster ME Donnan PT MacDonald TM Sullivan FM Fahey T Adherence to antihypertensive medication and association with patient and practice factors J Hum Hypertens 2006 20 4 295 297 10.1038/sj.jhh.1001981 16424861 · DOI
  20. [31]Karademir M Koseoglu IH Vatansever K Van Den Akker M Validity and reliability of the Turkish version of the Hill-Bone compliance to high blood pressure therapy scale for use in primary health care settings Eur J Gen Pract 2009 15 4 207 211 10.3109/13814780903452150 20055720 · DOI
  21. [32]Lavsa SM Holzworth A Ansani NT Selection of a validated scale for measuring medication adherence J Am Pharm Assoc 2011 51 1 90 94 10.1331/JAPhA.2011.09154 21247831 · DOI
  22. [33]Song Y Han HR Song HJ Nam S Nguyen T Kim MT Psychometric evaluation of hill-bone medication adherence subscale Asian Nurs Res 2011 5 3 183 188 10.1016/j.anr.2011.09.007 25030368 · DOI
  23. [34]Uchmanowicz I Jankowska-Polańska B Chudiak A Szymańska-Chabowska A Mazur G Psychometric evaluation of the polish adaptation of the hill-bone compliance to high blood pressure therapy scale BMC Cardiovasc Disord 2016 16 87 10.1186/s12872-016-0270-y 27165782 PMC4862115 · DOI
  24. [35]Mafutha GN Wright SC Compliance or non-compliance of hypertensive adults to hypertension management at three primary healthcare day clinics in Tshwane Curationis 2013 36 1 E1 E6 10.4102/curationis.v36i1.52 26697613 · DOI
  25. [37]Demoner MS Ramos ERDP Pereira ER Factors associated with adherence to antihypertensive treatment in a primary care unit Acta Paulista de Enfermagem 2012 25 Special Issue 1 27 34 10.1590/S0103-21002012000800005 · DOI
  26. [39]Jones JK Gorkin L Lian JF Staffa JA Fletcher AP Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population BMJ 1995 311 7000 293 295 10.1136/bmj.311.7000.293 7633238 PMC2550362 · DOI
  27. [40]Ma C A cross-sectional survey of medication adherence and associated factors for rural patients with hypertension Appl Nurs Res 2016 31 94 99 10.1016/j.apnr.2016.01.004 27397825 · DOI
  28. [41]Ambaw AD Alemie GA W/Yohannes SM Mengesha ZB Adherence to antihypertensive treatment and associated factors among patients on follow up at University of Gondar Hospital, Northwest Ethiopia BMC Public Health 2012 12 282 10.1186/1471-2458-12-282 22490130 PMC3395566 · DOI
  29. [42]Coleman R Gill G Wilkinson D Noncommunicable disease management in resource-poor settings: a primary care model from rural South Africa Bull World Health Organ 1998 76 6 633 640 10191559 PMC2312489
  30. [43]Erhun WO Agbani EO Bolaji EE Positive benefits of a pharmacist-managed hypertension clinic in Nigeria Public Health 2005 119 9 792 798 10.1016/j.puhe.2004.11.009 15990127 · DOI
  31. [44]Saounatsou M Patsi O Fasoi G Stylianou M Kavga A Economou O The influence of the hypertensive patient’s education in compliance with their medication Public Health Nurs 2001 18 6 436 442 10.1046/j.1525-1446.2001.00436.x 11737812 · DOI
  32. [45]Yiannakopoulou E Papadopulos JS Cokkinos DV Mountokalakis TD Adherence to antihypertensive treatment: a critical factor for blood pressure control Eur J Cardiovasc Prev Rehabil 2005 12 3 243 249 10.1097/00149831-200506000-00010 15942423 · DOI
  33. [47]Adams AS Uratsu C Dyer W Magid D O’Connor P Beck A Health system factors and antihypertensive adherence in a diverse cohort of new users JAMA Intern Med 2013 173 1 54 61 10.1001/2013.jamainternmed.955 23229831 PMC5105889 · DOI
  34. [48]Akeroyd JM Chan WJ Kamal AK Palaniappan L Virani SS Adherence to cardiovascular medications in the South Asian population: a systematic review of current evidence and future directions World J Cardiol 2015 7 12 938 947 10.4330/wjc.v7.i12.938 26730300 PMC4691821 · DOI
  35. [49]Harmon G Lefante J Krousel-Wood M Overcoming barriers: the role of providers in improving patient adherence to antihypertensive medications Curr Opin Cardiol 2006 21 4 310 315 10.1097/01.hco.0000231400.10104.e2 16755199 · DOI
  36. [50]Mancia G Fagard R Narkiewicz K Redon J Zanchetti A Bohm M 2013 European Society of Hypertension/European Society of Cardiology(ESH/ESC) guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension J Hypertens 2013 31 7 1281 1357 10.1097/01.hjh.0000431740.32696.cc 23817082 · DOI · Paper page
  37. [51]Rwegerera G, Moshomo T, Gaenamong M, Oyewo TA, Gollakota S, Mhimbira FA, et al. Antidiabetic medication adherence and associated factors among patients in Botswana; implications for the future. Alex J Med. 2017; 10.1016/j.ajme.2017.01.005. · DOI

Cited by

Sorted by citations

Authors
Nashilongo, M. M., Singu, B., Kalemeera, F., Mubita, M., Naikaku, E., Baker, A., Ferrario, A., Godman, B., Achieng, L., & Kibuule, D.
Affiliations
  • University of Namibia (NA)
  • London School of Economics and Political Science (GB)
  • Karolinska University Hospital (SE)
  • University of Nairobi (KE)
Corresponding author
Godman, B.
Venue
Cardiovascular Drugs and Therapy
Published
2017-10-14
Volume
31
Issue
5-6
Pages
565-578
ISSN
  • 0920-3206 (ISSN-L)
  • 1573-7241
OpenAlex
W2743658562
Cited by
87
References
46
Citations by year
2026: 2 · 2025: 7 · 2024: 5 · 2023: 10 · 2022: 8 · 2021: 16 · 2020: 19 · 2019: 13 · 2018: 5 · 2017: 2
FWCI
11.10
Type
journal article
Language
en
Open access
Locations
  • Cardiovascular Drugs and Therapy (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • London School of Economics and Political Science Research Online (London School of Economics and Political Science) (acceptedVersion)
  • London School of Economics and Political Science Research Online (London School of Economics and Political Science) (submittedVersion, cc-by)
  • Strathprints: The University of Strathclyde institutional repository (University of Strathclyde) (submittedVersion, cc-by)
  • Greater South Information System
Funders
Karolinska Institute
Topics
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacy and Medical Practices
Keywords
antihypertensive medication adherence, hypertension, scale validation, predictors of adherence, family support, follow-up visits, missed appointments, HIV/AIDS, universal health coverage, primary care
MeSH terms
Assessment of Medication Adherence, Antihypertensive Agents, Cross-Sectional Studies, Humans, Hypertension, Namibia, Primary Health Care, Drug Monitoring, Principal Component Analysis, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review